Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunocore Holdings (IMCR) Other Working Capital Changes (2023 - 2025)

Historic Other Working Capital Changes for Immunocore Holdings (IMCR) over the last 3 years, with Q3 2025 value amounting to $9.3 million.

  • Immunocore Holdings' Other Working Capital Changes rose 39951.4% to $9.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.4 million, marking a year-over-year decrease of 7071.23%. This contributed to the annual value of $11.6 million for FY2024, which is 2272.85% down from last year.
  • According to the latest figures from Q3 2025, Immunocore Holdings' Other Working Capital Changes is $9.3 million, which was up 39951.4% from -$5.1 million recorded in Q2 2025.
  • In the past 5 years, Immunocore Holdings' Other Working Capital Changes ranged from a high of $33.1 million in Q4 2023 and a low of -$18.1 million during Q1 2023
  • Moreover, its 3-year median value for Other Working Capital Changes was $1.9 million (2024), whereas its average is $2.9 million.
  • Within the past 5 years, the most significant YoY rise in Immunocore Holdings' Other Working Capital Changes was 39951.4% (2025), while the steepest drop was 32778.03% (2025).
  • Over the past 3 years, Immunocore Holdings' Other Working Capital Changes (Quarter) stood at $33.1 million in 2023, then crashed by 82.79% to $5.7 million in 2024, then soared by 62.58% to $9.3 million in 2025.
  • Its Other Working Capital Changes was $9.3 million in Q3 2025, compared to -$5.1 million in Q2 2025 and $1.6 million in Q1 2025.